ARV Supply Expected To Stabilise As Court Battle Ends

Monday, November 18, 2019

The supply of Anti Retroviral (ARV) drugs is expected to stabilise after government won a marathon court battle against one of the major suppliers, Portfolio Pharmaceuticals.

The company had cited irregularities in awarding of a tender for the supply of the drugs, after Portfolio Pharmaceuticals lost a significant share of the market to other players.

Following that, a lengthy court battle ensued, which had affected supply, with some patients receiving a weekly, rather than their monthly allocations.

Already have an active account? Log in here.

Or Sign up and get unlimited access to premium articles.

Rolling back: Rollers will want to turnaround its fortunes PIC: PHATSIMO KAPENG

Rollers, Orapa brace for two-part sequel

Kabelo Boranabi | 9 h ago

Faulty gadgets top complaints to BOCRA

Mbongeni Mguni | 2d ago

Civil Society fights 'flawed' constitutional amendment

Innocent Selatlhwa | 22 Apr 2024

Civil Society calls for Constitution review governing Act

Innocent Selatlhwa | 22 Apr 2024

IEC rejects 2,513 registrations

Innocent Selatlhwa | 22 Apr 2024

Motshegwa prevails against detractors

Goitsemodimo Kaelo | 22 Apr 2024

The recent disclosure by the IEC that 2,513 registrations have been turned down due to various irregularities should prompt all Batswana to meticulously review the voters' rolls and address concerns about rejected registrations.The disparities flagged by the IEC are troubling and emphasise the significance of rigorous voter registration processes.Out of the rejected registrations, 29 individuals were disqualified due to non-existent Omang...

The Monitor Editor | 23 April 2024

About us

Mmegi is the leading independent source of breaking news, latest news, current
affairs, Politics, Business, Sport, debates, analysis, and entertainment news in Botswana.

Explore

More

ARV Supply Expected To Stabilise As Court Battle Ends

The supply of Anti Retroviral (ARV) drugs is expected to stabilise after government won a marathon court battle against one of the major suppliers, Portfolio Pharmaceuticals.

Rollers, Orapa brace for two-part sequel

Stanbic pretax profits up 11%

The audacity to be a unicorn

Faulty gadgets top complaints to BOCRA

Civil Society fights 'flawed' constitutional amendment

Civil Society calls for Constitution review governing Act

IEC rejects 2,513 registrations

Motshegwa prevails against detractors

Inspect the voters' roll!